Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition

Diabetes

Volumn 47, Issue 3, 1998, Pages 414-422

  Gilbert, Richard E ^a,b   Cox, Alison ^a   Wu, Leonard L ^a   Allen, Terri J ^a   Lennart Hulthen, U ^a   Jerums, George ^a   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN ZINC SUSPENSION; MESSENGER RNA; RAMIPRIL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; GENE EXPRESSION; IN SITU HYBRIDIZATION; KIDNEY INTERSTITIUM; KIDNEY TUBULE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; COHORT STUDIES; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY TUBULES; MALE; RAMIPRIL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031892401     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.3.414     Document Type: Article

References (52)

1. Ong ACM, Fine LG: Loss of glomerular function and tubulointerstitial fibrosis. Kidney Int 45:245-251,1994
2. Eddy AA Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287,1994
3. Eddy A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
4. Lane PH, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus, Kidney Int 43:661-667,1993
5. Mauer S, Steffes M, Ellis E, Sutherland D, Brown D, Goetz F: Structural-functional relationships in diabetic nephropathy.J Clin Invest 74:1143-1155,1984
6. Bader R, Bader E, Grung KE, Markensen-Haen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 167:204-216,1980
7. Ceol M, Nerlich A, Baggio B, Angalani F, Sauer U, Schleicher E, Gambaro G: Increased glomerular alpha (IV) collagen expression and deposition in long term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 74:484-495, 1996
8. Williamson JR, Tilton RG, Chang K, Kilo C: Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab Rev 4:339-370,1988
9. Ziyadeh FN: Renal tubular basement membrane and collagen type IV in diabetes meffltus. Kidney Int 43:114-120,1993
10. Border WA, Yamamoto T, Noble NA: Transforming growth factor-β in diabetic nephropathy, Diabetes Metab Rev 12:309-339,1996
11. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
12. Wu L, Cox A, Roe C, Dziadek M, Cooper ME, Gilbert RE: 'Transforming growth factor βl and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 51:1553-1567,1997
13. Pimentel JJ, Sundell CL, Wang S, Kopp JB, Montero A, Martinez MM: Role of angiotensin II in the expression and regulation of transforming growth factorbeta in obstructive nephropathy. Kidney Int 48:1233-1246,1995
14. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294,1995
15. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (the Collaborative Study Group): The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462,1993
16. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282,1973
17. Jerums G, Allen TJ, Cooper ME; Triphasic changes in selectivity with increasing proteinuria in type I and type II diabetes. Diabet Med 6:772-779, 1989
18. Cooper ME, Rumble JR, Allen T, O'Brien RC, Jerums G, Doyle AE: Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int 41:898-903, 1992
19. Andrews PM, Coffey AK A technique to reduce fixation artifacts in kidney proximal tubules. Kidney Int 25:964-968,1984
20. Gilbert RE, Goodall I, Young V, Jerums G: Interlaboratory variation in GHb assays in Victoria, Australia Diabetes Care 19:730-734,1996
21. Allen TJ, Cooper ME, Gilbert RE, Winikoff J, Skinner SL, Jerums G: Serum total renin is increased before microalbuminuria in diabetes. Kidney Int 50:902-907, 1996
22. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119,1996
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159,1987
24. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME, Jerums G: SPARC gene expression is reduced in early diabetes related kidney growth. Kidney Int 48:1216-1225,1995
25. Cattoretti G, Pileri S, Parraviocini C, Becker MHG, Poggi S, Bifulco C, Key G, Damato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F: Antigen unmasking on formal in-fixed, paraffin-embedded tissue sections. J Pathol 171:83-98,1993
26. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilben RE: Vascular hypertrophy in experimental diabetes: role of advanced glycation end products, J Clin Invest 99:1016-1027,1997
27. Park I-S, Kiyomoto H, Abboud SL, Abboud HE: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480,1997
28. Lane P, Steffes MW. Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667,1993
29. Taft J, Nolan CJ, Yeung SP, Hewitson TD, Martin FIR: Clinical and histologi- cal correlations of decline in renal function in diabetic patients with protein uria. Diabetes 43:1046-1051,1994
30. Fioretto P, Steffes MW, Sutherland DER, Mauer SM: Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int 48:1929-1935,1995
31. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 259:F704-F714,1990
32. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGFbeta gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114,1992
33. Fioretto P, Steffes MW, Brown DM, Mauer SM: An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis 20:549-558,1992
34. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334,1991
35. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744,1993
36. Ihm CG, Lee GS, Nast CC, Artishevsky A, Guillermo R, Levin PS, Glassock RJ, Adler SG: Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768-777,1992
37. Arison RN, Ciaccio EI, Glitzer MS, Cassaro JA, Pruss MP: Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16:51-56, 1967
38. Kasiske B, Kalil R, Ma J, Liao M, Keane W: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129-138,1993
39. Laffel LM, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria: North American Microalbuminuria Study Group. Am J Med 99:497-504,1995
40. Cooper ME, Alien TJ, Macmillan PA, Clarke BE, Jerums G, Doyle AE: Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat Diabetologia 32:326-328,1989
41. Zatz R, Dunn BR, Meyer TW, Brenner B: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1030,1986
42. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tbmino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497,1995
43. Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Tomino Y, Koide H: Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J Lab Clin Med 123:763-768,1994
44. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486,1993
45. Everett A, Scott J, Wilfong N, Marino-B, Rosenkranz R, Inagami T, Gomez R: Renin and angiotensinogen expression during the evolution of diabetes. Hypertension 19:70-78, 1992
46. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M: The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 4:1337-1345, 1993
47. Correa Rotter R, Hostetter TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int. 41:796-804,1992
48. Rosenberg M, Smith L, Correa-Rotter R, Hostetter T: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410,1994
49. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
50. Koya D, Jirousek MR, You-Wei L, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126,1997
51. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, Nairns RG: Cyclic stretching force selectively upregulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am J Pathol 148:1915-1923,1996
52. Kovacs EJ, DiPietro LA: Fibrogenic cytokines and connective tissue production. FASEB J 8:854-861,1994